Last €20.29 EUR
Change Today -0.02 / -0.10%
Volume 18.2K
DBV On Other Exchanges
Symbol
Exchange
EN Paris
OTC US
Xetra
As of 11:35 AM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George F. Horner III

AgeTotal Calculated CompensationThis person is connected to 52 board members in 4 different organizations across 12 different industries.

See Board Relationships
69€10,000

Background*

Mr. George F. Horner, III, served as an Entrepreneur-in-Residence of Sofinnova Ventures, Inc. Mr. Horner served as the Chief Executive Officer and President of Prestwick Pharmaceuticals Inc. since joining in August 2006. He served as the Principal Accounting Officer of Durata Therapeutics, Inc. (also known as Vicuron Pharmaceuticals Inc) and served as its Chief Executive Officer and President from 1996 to September 2005. He has 40 years of U.S. and international experience ...

Read Full Background

Corporate Headquarters*

Green Square
Bagneux, Ile-de-France 92220

France

Phone: 33 1 55 42 78 78
Fax: 33 1 43 26 10 83

Board Members Memberships*

Former Director
Chairman
1996-N/A
Former Chief Executive Officer, President, Principal Accounting Officer and Director
2006-2009
Former Independent Director, Member of Audit Committee, Member of Compensation Committee and Member of Transactions Committee
2007-Present
Non-Executive Director
2009-2012
Former Independent Director
2010-Present
Chairman
2010-2013
Former Chairman
2011-Present
Director

Education*

BA
Abbey Belmont College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation€10,000
Total Calculated Compensation€10,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DBV:FP €20.29 EUR -0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Christian Chavy Chief Executive Officer, Director, Member of Audit Committee and Member of Strategic & Corporate Development Committee
Stallergenes S.A.
--
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Manuel Llobet Chief Executive Officer and Executive Director
Allergy Therapeutics plc
218.0K GBP
Jens Bager Chief Executive Officer, President and Member of the Board of Management
ALK-Abelló A/S
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DBV TECHNOLOGIES SA, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.